Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
3.95
↑ 48% above average
Average (9y)
2.67
Historical baseline
Range
High:4.41
Low:1.08
CAGR
+8.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 3.95 | +131.9% |
| 2024 | 1.70 | +57.5% |
| 2023 | 1.08 | -67.5% |
| 2022 | 3.33 | +15.9% |
| 2021 | 2.87 | +43.2% |
| 2020 | 2.00 | -21.2% |
| 2019 | 2.54 | -42.3% |
| 2018 | 4.41 | +49.2% |
| 2017 | 2.96 | +58.5% |
| 2016 | 1.87 | - |